Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - LONG-TERM DEBT
Long-term Debt NTLA - Intellia Therapeutics, Inc.
96.7 M
LAST VALUE
22.08%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR